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Abstract
Mother’s own milk (MOM) is the first choice in preterm infant feeding, 
and when it is not available or is insufficient, donor human milk (DHM) is 
recommended. It has been shown that feeding preterm infants with human milk 
is less related to major morbidities, enhances feeding tolerance and prevents 
metabolic syndrome in childhood. As The Committee on Nutrition of the 
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 
(ESPGHAN) states, specific guidelines for Human Milk Banks (HMB) are 
needed to guarantee the best possible compromise between microbiological 
safety and nutritional/biological quality of human milk (HM). 
Currently, Holder pasteurization (HoP: pasteurization process at 62.5-63°C 
for 30 minutes) is recommended by all international guidelines: this method 
inactivates bacterial and viral pathogens but it also affects some nutritional 
and biological properties of human milk. New methods to ameliorate the 
biological quality and safety of DHM are under investigation in the last 
years. High Pressure Processing (HPP) is a non- thermal process used in 
food industries: this technology inactivates pathogenic microorganisms by 
applying hydrostatic high pressure, however further researches are required 
before applying this technology in milk banking. 
Ultraviolet-C irradiation (UV-C) is another non-thermal method capable 
of reducing vegetative bacteria in human milk and it also seems to preserve 
higher levels of immunological proteins than HoP. 
High-temperature short-time pasteurization (HTST: flash pasteurization, 
72°C for 5-15 seconds) currently is available only at industrial level, but it 
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could represent an alternative to HoP seeming to 
maintain the protein profile and some of the key 
active components of DHM. 
Further researches are needed to define the 
optimal treatment of DHM.
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Introduction
Growing evidence support the use of human 
milk (HM) for term and preterm infants as well as 
for sick infants in Neonatal Intensive Care Units 
(NICUs) [1-3]. Mother’s own milk (MOM) is 
the first choice in preterm infant feeding. When 
mother’s milk is not available or is insufficient, 
donor human milk (DHM) is recommended [1-5]. 
Some authors who applied Baby-Friendly Hospital 
Initiatives to NICUs has considered DHM as one 
of the supportive measures for the establishment of 
breastfeeding by [6, 7].
Benefits of feeding with donor human milk 
Reduction in the incidence of necrotizing 
enterocolitis (NEC). The main benefit deriving 
from the use of DHM vs. formula in preterm 
infant feeding is the reduction of incidence of 
necrotizing enterocolitis (NEC) as well explained 
in some meta-analyses [8-10] and also in some 
observational studies [10-12].
Reduction in the incidence of sepsis and other 
infections. A systematic review [13] underlined 
the protective effect of HM against infections in 
preterm infants. However, the studies included in 
this review present a wide heterogenicity regarding 
the definition of the milk utilized and do not allow to 
discriminate the effects deriving specifically from 
the use of DHM. A large prospective study [14] 
as well, showed that fresh HM or DHM feeding 
reduced the risk of late onset sepsis in extremely 
low birth weight or extremely premature infants. 
These findings have been confirmed only for 
fresh MOM in a later study [15]. Further studies 
evaluating specifically the anti-infective effects of 
DHM are needed.
Reduction in the incidence of bronchopulmonary 
dysplasia. It has been shown that DHM 
feeding significantly reduces the incidence of 
bronchopulmonary dysplasia in neonates born at 
a gestational age below 30 weeks [5, 15]. This 
observation shows an antioxidant activity of 
HM, which is likely to be maintained also after 
pasteurization.
Enhancement of feeding tolerance. It has 
been demonstrated that early initiation of enteral 
feeding with MOM or DHM even within the first 
hours of life is well tolerated [16]. In the 1980s few 
experimental studies observed a lower incidence 
of feeding intolerance and an earlier establishment 
of full enteral feeding in preterm infants fed with 
DHM compared to formula [9]. 
Prevention of hypertension, insulin resistance, 
and atherogenic lipoprotein profile. Several 
studies conducted in large cohorts suggest that 
adolescents born preterm and fed with human milk 
present lower risk of metabolic syndrome and 
lower cardiovascular risk [1-2, 17]. 
Promotion of breastfeeding in NICU: a recent 
national survey in Italy observed a positive effects 
of the availability of DHM on breastfeeding rate of 
very low birth weight (VLBW) infants at discharge 
[18], confirming the existing data from Australia 
[19], USA [20], and Spain [21] which already 
indicate that the presence of a HMB does not 
decrease the breastfeeding rate of VLBW infants, 
but instead, it is supportive for breastfeeding 
promotion.
Human milk banks 
The recent commentary of The Committee on 
Nutrition of the European Society for Pediatric 
Gastroenterology, Hepatology, and Nutrition 
(ESPGHAN) states that “DHM should be obtained 
from established Human Milk Banks (HMBs) 
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that follow specific guidelines for screening, 
storage, and handling procedures to optimize 
its composition while ensuring its safety for the 
recipient” [5].
Milk handling and processing should always 
follow the principles of Hazard Analysis and 
Critical Control Points (HACCP) and should 
represent the best possible compromise between 
safety and nutritional/biological quality of the 
product.
Many countries now have their own HMBs 
guidelines [23-27].
Donor human milk treatment in human milk 
banks 
Milk delivered to the HMBs should be 
pasteurized to inactivate viral and bacterial agents 
[5]. The ideal pasteurization process should consist 
of a phase of rapid heating, followed by a phase in 
which the temperature is maintained constant, and 
a final phase of rapid cooling. 
Currently, a pasteurization process at 62.5-
63°C for 30 minutes (i.e. the Holder pasteurization 
[HoP]) is recommended by all international 
guidelines for constitution of HMBs [27] (level 
of evidence A: at least two good quality coherent 
studies, where bias or confounding factors are 
not present). Pasteurized milk is known to retain 
many beneficial and protective effects of HM. 
This method allows a good compromise between 
microbiological safety and nutritional/biological 
quality of DHM [2, 4-5, 27]. In fact, it destroys 
pathogens in milk, including M. tuberculosis, and 
B. cereus, as well as some viruses (HIV, HTVL 
1-2, Cytomegalovirus, Herpes Simplex and 
Rubella) [25, 33-39]. But it is also well known that 
HoP affects some of the nutritional and biological 
properties of human milk. Several studies have 
been performed to investigate the effects of 
Holder pasteurization on these properties of HM 
and a significant variability in the data is reported 
in the scientific literature. A possible explanation 
for the different results may be the heterogeneity 
of the test protocols applied in the studies (e.g. 
in terms of sample origin, storage conditions or 
methods of analysis). Another important source of 
variability is represented by the fact that often HoP 
of DHM is simulated on small aliquots, rather than 
being performed following HMB-implemented 
protocols. Moreover, modern pasteurizers required 
significantly less time for heating and cooling than 
older ones, thus changing the kinetics of the thermal 
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response for many heat-sensible compounds. 
Additionally, it appears that some biochemical 
patterns were investigated more extensively than 
others, while some other milk components were 
not considered at all. 
The available data confirm that the HoP 
affects several components of HM (such as 
immunoglobulins, specific enzymatic activities, 
vitamins, growth factors and cytokines), even if 
it is rather difficult to quantify the degradation 
degree [2, 5].
Furthermore, HoP maintains the bactericidal 
activity of the milk against E. coli better than high 
temperature short term pasteurization (HTST) 
[53]. Moreover, although HoP decreases IgA 
concentration, the remaining molecules effectively 
inhibit bacterial adhesion (enteropathogenic 
E. coli) [54]. Nonetheless, clinical practice 
demonstrates that many beneficial properties of 
HM remains even after pasteurization.
The optimal treatment of DHM should aim to 
maintain microbiological safety while preserving 
the highest amount and activity of the milk 
bioactive components. New methods to improve 
the biological quality and safety of DHM are under 
investigation.
High Pressure Processing (HPP) has recently 
received attention as a novel food preservation 
method. This non thermal process is an emerging 
food processing method that can be applied to 
liquid foods to provide microbiologically safe, 
nutritionally intact and organoleptically high 
quality products. This technology inactivates 
pathogenic microorganisms by applying 
hydrostatic high pressure (usually 400-800 MPa) 
to food for short-term treatments (less than 5-10 
min). However, further researches are required 
before applying this technology in milk banking 
[40-41].
Ultraviolet-C irradiation (UV-C), classified 
as a non thermal method, seems to be capable of 
reducing vegetative bacteria in HM as required in 
HMBs guidelines with no loss of bile salt stimulated 
lipase (BSSL) and alkaline phosphatase (ALP) 
activity and no change of fatty acids (FA) [42]. 
This method also seems to preserve significantly 
higher levels of immunological proteins than HoP, 
resulting in bacteriostatic properties similar to 
those of untreated HM [43].
HTST (flash pasteurization, 72°C for 5-15 
seconds) is a pasteurization method in use in 
the food industries and this thermal treatment 
has been suggested as an alternative to the HoP. 
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HTST seems to better retain the protein profile and 
some of the key active components of DHM (bile 
salt-stimulated lipase, lactoferrin, IgA, IGFs) if 
compared to HoP [44-57]. However, this method 
requires technological investment (a thin layer 
of milk between two heated metallic walls) and 
currently is available only at industrial level. 
A new high-tech method of flash pasteurization 
for low quantity of HM has been recently patented 
by our group and is, at present, ongoing validation.
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